As of 2025-07-01, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -13,728.55 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.32 USD, the upside of Evelo Biosciences Inc is -4,337,714.50%.
Based on its market price of 0.32 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 4,337,714.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13,728.55 - -13,728.55 | -13,728.55 | -4,337,714.50% |
| P/E | (27,017.76) - (48,159.71) | (35,007.77) | -11061007.8% |
| DDM - Stable | (13.37) - (24.81) | (19.09) | -6130.7% |
| DDM - Multi | (16.36) - (21.62) | (18.57) | -5967.0% |
| Market Cap (mil) | 0.01 |
| Beta | -0.40 |
| Outstanding shares (mil) | 0.03 |
| Enterprise Value (mil) | 16.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 12,174.37% |
| Cost of Debt | 5.00% |
| WACC | 7.63% |